Ke-Wang Luo

1.1k total citations
29 papers, 918 citations indexed

About

Ke-Wang Luo is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ke-Wang Luo has authored 29 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 7 papers in Pharmacology. Recurrent topics in Ke-Wang Luo's work include Tea Polyphenols and Effects (6 papers), Bone health and treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Ke-Wang Luo is often cited by papers focused on Tea Polyphenols and Effects (6 papers), Bone health and treatments (5 papers) and Immune Cell Function and Interaction (4 papers). Ke-Wang Luo collaborates with scholars based in China, Hong Kong and Australia. Ke-Wang Luo's co-authors include Kwok‐Pui Fung, Shihua Wu, Lu Yang, Weiren Huang, Bao‐Hui Cheng, Feiyan Liu, Jianguo Sun, Judy Yuet‐Wa Chan, Hanchao Gao and Chun‐Hay Ko and has published in prestigious journals such as PLoS ONE, Frontiers in Immunology and Molecules.

In The Last Decade

Ke-Wang Luo

27 papers receiving 901 citations

Peers

Countries citing papers authored by Ke-Wang Luo

Since Specialization

Citations

This map shows the geographic impact of Ke-Wang Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke-Wang Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke-Wang Luo more than expected).

Fields of papers citing papers by Ke-Wang Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke-Wang Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke-Wang Luo. The network helps show where Ke-Wang Luo may publish in the future.

Co-authorship network of co-authors of Ke-Wang Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ke-Wang Luo. A scholar is included among the top collaborators of Ke-Wang Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke-Wang Luo. Ke-Wang Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Caspase‐6/Gasdermin C‐Mediated Tumor Cell Pyroptosis Promotes Colorectal Cancer Progression Through CXCL2‐Dependent Recruitment of Myeloid‐Derived Suppressor Cells 2025 ·Advanced Science ·Hanchao Gao, Yikun Yao, (unknown), (unknown), Wenjun Hu, Ke-Wang Luo, Peishan Chen, (unknown), (unknown), Shaodong Luan, Guojun Shi, Mengtao Cao, Pengfei Chen	2
2	KSQ‐4279, an Inhibitor of Ubiquitin Specific Peptidase 1, Enhanced the Chemotherapeutic Efficacy in ABCB1/ABCG2/ABCC1‐Mediated Multidrug Resistant Cancers 2025 ·MedComm ·Qihong Yang, Ke-Wang Luo, Kenneth K.W. To, (unknown), Kai Fu, Shuangli Zhu, Sijia Li, Fang Wang, Chuan‐An Wu, Liwu Fu	0
3	Neutrophil-mediated immune dysregulation in recurrent miscarriage: implications of APP–CD74 signaling and CXCL1 as diagnostic biomarkers 2025 ·Frontiers in Immunology ·(unknown), Fei Ma, Meng Yu, Jiaman Wu, Yabin Gong, Ke-Wang Luo, Hong Chang, Liang Qi, (unknown)	0
4	Immunotherapies Targeting Tumor-Associated Macrophages (TAMs) in Cancer 2024 ·Pharmaceutics ·(unknown), (unknown), Ke-Wang Luo	17
5	Gasdermin D promotes development of intestinal tumors through regulating IL-1β release and gut microbiota composition 2024 ·Cell Communication and Signaling ·Hanchao Gao, (unknown), Shi Xu, (unknown), Wenjun Hu, (unknown), Ke-Wang Luo, Ting Xie, Yan Yu, Huimin Sun, Liwen Huang, Peishan Chen, Jinmei Wu, Dexing Yang, Lian Li, Shaodong Luan, Mengtao Cao, Pengfei Chen	2
6	BI-2865, a pan-KRAS inhibitor, reverses the P-glycoprotein induced multidrug resistance in vitro and in vivo 2024 ·Cell Communication and Signaling ·Qihong Yang, Kenneth K.W. To, Guilin Hu, Kai Fu, Chuan Yang, Shuangli Zhu, (unknown), Fang Wang, Ke-Wang Luo, Liwu Fu	4
7	Therapies Targeting Immune Cells in Tumor Microenvironment for Non-Small Cell Lung Cancer 2023 ·Pharmaceutics ·(unknown), Meiye Li, Ke-Wang Luo	6
8	EGCG Enhanced the Anti-tumor Effect of Doxorubicine in Bladder Cancer via NF-κB/MDM2/p53 Pathway 2020 ·Frontiers in Cell and Developmental Biology ·Ke-Wang Luo, Xiaohong Zhu, Ting Zhao, (unknown), Hanchao Gao, (unknown), Weiren Huang	28
9	Isolation and Culture of Primary Aortic Endothelial Cells from Miniature Pigs 2019 ·Journal of Visualized Experiments ·Yanli Zhao, (unknown), David K. C. Cooper, Ying Lu, Ke-Wang Luo, (unknown), Pengfei Chen, Changchun Zeng, Shaodong Luan, Lisha Mou, Hanchao Gao	4
10	Evaluation of the combined use of metronomic zoledronic acid and Coriolus versicolor in intratibial breast cancer mouse model 2017 ·Journal of Ethnopharmacology ·Chun‐Hay Ko, Grace Gar‐Lee Yue, Si Gao, Ke-Wang Luo, Wing Sum Siu, (unknown), (unknown), Julia Kin-Ming Lee, Gang Li, Ping‐Chung Leung, Andreas Evdokiou, Clara Bik‐San Lau	16
11	EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9 2016 ·The Journal of Nutritional Biochemistry ·Ke-Wang Luo, Wei Chen, (unknown), (unknown), Bao‐Hui Cheng, Zhiming Cai, Weiren Huang	112
12	The combined use of Camellia sinensis and metronomic zoledronate in 4T1 mouse carcinoma against tumor growth and metastasis 2015 ·Oncology Reports ·Ke-Wang Luo, Grace Gar‐Lee Yue, Chun‐Hay Ko, Si Gao, Julia Kin-Ming Lee, Gang Li, Kwok‐Pui Fung, Ping‐Chung Leung, Clara Bik‐San Lau	12
13	Green tea (Camellia sinensis) extract inhibits both the metastasis and osteolytic components of mammary cancer 4T1 lesions in mice 2014 ·The Journal of Nutritional Biochemistry ·Ke-Wang Luo, Chun‐Hay Ko, Grace Gar‐Lee Yue, Julia Kin-Ming Lee, (unknown), Michelle Lee, Gang Li, Kwok‐Pui Fung, Ping‐Chung Leung, Clara Bik‐San Lau	51
14	Pharmacologic inhibition of bone resorption prevents cancer-induced osteolysis but enhances soft tissue metastasis in a mouse model of osteolytic breast cancer 2014 ·International Journal of Oncology ·Irene Zinonos, Ke-Wang Luo, Agatha Labrinidis, Vasilios Liapis, Shelley Hay, Vasilios Panagopoulos, Mark DeNichilo, Chun‐Hay Ko, Grace Gar‐Lee Yue, Clara Bik‐San Lau, Wendy V. Ingman, Vladimir Ponomarev, Gerald J. Atkins, David M. Findlay, Andrew C.W. Zannettino, Andreas Evdokiou	19
15	The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model 2014 ·Journal of Cancer Research and Clinical Oncology ·Ke-Wang Luo, Chun‐Hay Ko, Grace Gar‐Lee Yue, Si Gao, Julia Kin-Ming Lee, Gang Li, Kwok‐Pui Fung, Ping‐Chung Leung, Andreas Evdokiou, Clara Bik‐San Lau	10
16	Anti-tumor and anti-osteolysis effects of the metronomic use of zoledronic acid in primary and metastatic breast cancer mouse models 2013 ·Cancer Letters ·Ke-Wang Luo, Chun‐Hay Ko, Grace Gar‐Lee Yue, Michelle Y. Y. Lee, Wing Sum Siu, (unknown), (unknown), Kwok‐Pui Fung, Ping‐Chung Leung, Gang Li, Andreas Evdokiou, Clara Bik‐San Lau	13
17	Clitocine Reversal of P-Glycoprotein Associated Multi-Drug Resistance through Down-Regulation of Transcription Factor NF-κB in R-HepG2 Cell Line 2012 ·PLoS ONE ·Jianguo Sun, (unknown), Ngai Na Co, Tsun Yee Tsang, (unknown), Ke-Wang Luo, Pin Wu, Judy Yuet‐Wa Chan, Kwok‐Pui Fung, T.T. Kwok, Feiyan Liu	57
18	Anticancer Effects of Imperatorin Isolated from Angelica dahurica: Induction of Apoptosis in HepG2 Cells through both Death-Receptor- and Mitochondria-Mediated Pathways 2011 ·Chemotherapy ·Ke-Wang Luo, Jianguo Sun, Judy Yuet‐Wa Chan, Lu Yang, Shihua Wu, Kwok‐Pui Fung, Feiyan Liu	126
19	Suillin from the mushroom Suillus placidus as potent apoptosis inducer in human hepatoma HepG2 cells 2009 ·Chemico-Biological Interactions ·Feiyan Liu, Ke-Wang Luo, Zhiming Yu, (unknown), Shihua Wu, Pin Wu, Kwok‐Pui Fung, (unknown)	30
20	Andrographolide enhances 5-fluorouracil-induced apoptosis via caspase-8-dependent mitochondrial pathway involving p53 participation in hepatocellular carcinoma (SMMC-7721) cells 2008 ·Cancer Letters ·Lu Yang, (unknown), Ke-Wang Luo, Shihua Wu, Ping Wu	91

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact